9 Organisations

Technology, Data, & Software Platforms

Digital therapeutics, neurotechnology, AI, and data analytics platforms building the tech infrastructure for psychedelic medicine.

Specific Groups

All Organisations

Journey Clinical

Care-delivery platform for ketamine-assisted psychotherapy enabling licensed therapists to deliver KAP through a coordinated technology and prescriber network model.

View Profile
United States

Kernel

Private Biotech

Neurotechnology company developing non-invasive brain measurement systems with applications in psychiatry and published psychedelic-adjacent ketamine research collaborations.

1 trial
View Profile

Mindbloom

Ketamine therapy platform combining telehealth, digital treatment flow, and app-guided support for depression and related mental health conditions.

View Profile

Mindstate Design Labs

Private BiotechPhase I

Clinical-stage AI neuroengineering platform company focused on designing psychoactive effect profiles and developing next-generation neuropsychiatric programs with psychedelic relevance.

View Profile

Nectara

Psychedelic-focused digital platform supporting protocolized care operations, patient journey tracking, and program management for providers and organizations.

View Profile

Nue Life

Digital ketamine treatment platform offering app-enabled preparation, guided sessions, and integration support for mental health care.

View Profile

Osmind

Psychiatry technology and real-world evidence platform supporting interventional mental health care, including psychedelic-assisted therapy workflows and psilocybin outcomes initiatives.

View Profile

Wake Network, Inc.

Psilocybin-focused organization with integration and program infrastructure, including digital and genomics-oriented support claims around therapeutic deployment.

1 trial
View Profile

Wavepaths

Digital therapeutic music platform built for psychedelic-assisted therapy workflows, with adaptive session design for psilocybin, MDMA, and ketamine contexts.

View Profile